May 19, 2022NuvOx Pharma Announces Issuance of a New PatentAward of this patent broadens NuvOx’s extensive patent portfolio of perfluorocarbon-based therapeutic formulations to reverse hypoxia.
May 9, 2022NuvOx Appoints Dr. Robert King to SABTucson, AZ, May 9th, 2022 – https://www.pr.com/press-release/861001 NuvOx Pharma, a clinical stage biotechnology company developing a...
May 9, 2022NuvOx Technology Featured in Prominent Peer Review JournalTucson, AZ, April 19, 2022 -- https://www.pr.com/press-release/859633 NuvOx Pharma’s technology, which is developed as a first-in-class...
May 9, 2022NuvOx Finalizes Facility Certification, Poising for Phase IIb TrialsTucson, AZ, April 17, 2022 -- https://www.pr.com/press-release/859467 NuvOx Pharma, a clinical stage biotechnology company developing a...